Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm
FDA: Guidance for Industry Duchenne Muscular Dystrophy Developing Drugs for Treatment Over the Spectrum of Disease
June 26, 2015 Patient-Centered Research To Support The Development Of The Symptoms Of Major Depressive Disorder Scale (SMDDS): Initial Qualitative Research
December 6, 2015 Development of a Patient-Reported Outcome Instrument to Assess Complex Activities of Daily Living and Interpersonal Functioning in Persons with Mild Cognitive Impairment: The Qualitative Research Phase
January 6, 2015 Patient-Reported Outcomes In Cancer Drug Development And US Regulatory Review: Perspectives From Industry, The Food And Drug Administration, And The Patient
The TREAT-NMD Advisory Committee for Therapeutics (TACT): An Innovative de-Risking Model to Foster Orphan Drug Development
